Additive effects of nicotine and high-fat diet on hepatic steatosis in male mice

Endocrinology

Volumn 153, Issue 12, 2012, Pages 5809-5820

  Friedman, Theodore C ^a,b   Sinha Hikim, Indrani ^a,b   Parveen, Meher ^a,b   Najjar, Sonia M ^c   Liu, Yanjun ^a,b   Mangubat, Michael ^a,b   Shin, Chang Sung ^a,b   Lyzlov, Alexei ^a,b   Ivey, Rasheed ^a,b   Shaheen, Magda ^a   French, Samuel W ^d   Sinha Hikim, Amiya P ^a,b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACIPIMOX; ALANINE AMINOTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NICOTINE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY FAT; BODY WEIGHT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FATTY LIVER; LIPID DIET; LIVER CELL; MALE; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; AMP-ACTIVATED PROTEIN KINASES; ANIMAL FEED; ANIMALS; APOPTOSIS; DIET, HIGH-FAT; ENDOPLASMIC RETICULUM; FATTY LIVER; HEPATOCYTES; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; NICOTINE; OXIDATIVE STRESS; RISK FACTORS; TRIGLYCERIDES;

EID: 84870155127     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1750     Document Type: Article

References (65)

1. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP, Klag MJ, Whelton PK 2005 Major causes of death among men and women in China. N Engl J Med 353:1124-1134
2. Barnes PJ 2003 New concepts in chronic obstructive pulmonary disease. Ann Rev Med 75:19-37
3. Hudson NL, Mannino DM 2010 Tobacco use: a chronic illness? J Community Health 35:549-553
4. Zaher C, Halbert R, Dubios R, George D, Nonikov D 2004 Smoking-related diseases: the importance of COPD. Int J Tuberc Lung 8:1423-1428
5. Farrell GC, Teoh NC, McCuskey RS 2008 Hepatic microcirculation in fatty liver disease. Anat Rec 291:684-692
6. Postic C, Girard J 2008 Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118:829-838
7. Trauner M, Arrese M, Wagner M 2010 Fatty liver and lipotoxicity. Biochem Biophys Acta 1801:299-310
8. Hamabe A, Uto H, Imamura Y, Kusano K, Mawatari S, Kumagai K, Kure T, Tamai T, Moriuchi A, Sakiyama T, Oketani M, Ido A, Tsubouchi H 2011 Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. J Gastroenterol 46:769-778
9. Zein CO, Unalp A, Colvin R, Liu YC, McCullough AJ 2011 Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol 54:753-759
10. Chiolero A, Faeh D, Paccaud F, Cornuz J 2008 Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 87:801-809
11. Haslam DW, James WP 2005 Obesity. Lancet 366:1197-1209
12. Flegal KM, Carroll MD, Ogden CL, Curtin LR 2010 Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-241
13. Friedman JM 2004 Modern science versus the stigma of obesity. Nat Med 10:563-569
14. Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ 2006 Alanine aminotransferase as a marker of nonalcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 22:437-443
15. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, Kawahito Y, Yoshida N, Suetsugu A, Kato T, Okuda J, Ida K, Yoshikawa T 2007 Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 13:1579-1584
16. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, Zenari L, Falezza G 2005 Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54:3541-3546
17. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH 2004 Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40:1387-1395
18. Browning JD, Horton JD 2004 Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114:147-152
19. Mangubat M, Lutfy K, Lee ML, Pulido L, Stout D, Davis R, Shin CS, Shahbazian M, Seasholtz S, Sinha-Hikim A, Sinha-Hikim I, O'Dell LE, Lyzlov A, Liu Y, Friedman TC 2012 Effect of nicotine on body composition in mice. J Endocrinol 212:317-326
20. Ahmadian M, Duncan RE, Sul HS 2009 The skinny on fat: lipolysis and fatty acid utilization in adipocytes. Trends Endocrinol Metab 20:424-428
21. DeFronzo RA 2010 Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 53:1270-1287
22. Azzalini L, Ferrer E, Ramalho LN, Moreno M, Domínguez M, Colmenero J, Peinado VI, Barberà JA, Arroyo V, Ginès P, Caballería J, Bataller R 2010 Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. Hepatology 51:1567-1576
23. Yuan H, Shyy JY, Martins-Green M 2009 Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1. J Hepatol 51:535-547
24. Behan JW, Avramis VI, Yun JP, Louie SG, Mittelman SD 2010 Diet-induced obesity alters vincristine pharmacokinetics in blood and tissues of mice. Pharmacol Res 61:385-390
25. Collins S, Martin TL, Surwit RS, Robidoux J 2004 Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 81:243-248
26. de Meijer VE, Le HD, Meisel JA, Akhavan Sharif MR, Pan A, NoséV, Puder M 2010 Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model. Metabolism 59:1092-1105
27. Patsch JM, Kiefer FW, Varga P, Pail P, Rauner M, Stupphann D, Resch H, Moser D, Zysset PK, Stulnig TM, Pietschmann P 2011 Increased bone resorption and impaired bone microarchitecture in short-term and extended high-fat diet-induced obesity. Metabolism 60:243-249
28. Sinha-Hikim I, Shen R, Nzenwa I, Gelfand R, Mahata SK, Sinha-Hikim AP 2011 Minocycline suppresses oxidative stress and attenuates fetal cardiac myocyte apoptosis triggered by in utero cocaine exposure. Apoptosis 16:563-573
29. Sinha-Hikim I, Shen R, Paul Lee WN, Crum A, Vaziri ND, Norris KC 2010 Effects of a novel cystine-based glutathione precursor on oxidative stress in vascular smooth muscle cells. Am J Physiol Cell Physiol 299:C638-C642
30. Sinha-Hikim I, Sinha-Hikim AP, Shen R, Kim HJ, Kim H, French SW, Vaziri ND, Vaziri ND, Crum AC, Crum A, Rajavashisth TB, Norris KC 2011 A novel cystine based antioxidant attenuates oxidative stress and hepatic steatosis in diet-induced obese mice. Exp Mol Pathol 91:419-428
31. Kohen R, Nyska A 2002 Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30:620-650
32. Tam NN, Gao Y, Leung YK, Ho SM 2003 Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth. Am J Pathol 163:2513-2522
33. Jia Y, Castellanos J, Wang C, Sinha-Hikim I, Lue Y, Swerdloff RS, Sinha-Hikim AP 2009 Mitogen-activated protein kinase signaling in male germ cell apoptosis in the rat. Biol Reprod 80:771-780
34. Vera Y, Erkkilä K, Wang C, Nunez C, Kyttänen S, Lue Y, Dunkel L, Swerdloff RS, Sinha Hikim AP 2006 Involvement of p38 mitogen-activated protein kinase and inducible nitric oxide synthase in apoptotic signaling of murine and human male germ cells after hormone deprivation. Mol Endocrinol 20:1597-1609
35. Deng QG, She H, Cheng JH, French SW, Koop DR, Xiong S, Tsukamoto H 2005 Steatohepatitis induced by intragastric overfeeding in mice. Hepatology 42:905-914
36. Cruz-Orive LM, Weibel ER 1990 Recent stereological methods for cell biology: a brief survey. Am J Physiol 258:L148-L156
37. Mahapatra NR, O'Connor DT, Vaingankar SM, Hikim AP, Mahata M, Ray S, Staite E, Wu H, Gu Y, Dalton N, Kennedy BP, Ziegler MG, Ross J, Mahata SK 2005 Targeted ablation of chromogranin A gene: elevated blood pressure rescued by human homolog. J Clin Invest 115:1942-1952
38. Hikim AP, Lue Y, Yamamoto CM, Vera Y, Rodriguez S, Yen PH, Soeng K, Wang C, Swerdloff RS 2003 Key apoptotic pathways for heat-induced programmed germ cell death in the testis. Endocrinology 144:3167-3175
39. Zhang BB, Zhou G, Li C 2009 AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab 9:407-416
40. Alkhouri N, Gornicka A, Berk MP, Thapaliya S, Dixon LJ, Kashyap S, Schauer PR, Feldstein AE 2010 Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J Biol Chem 285:3428-3438
41. Mantena S, King A, Andringa K, Eccleston H, Bailey S 2008 Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol 44:1259-1272
42. Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I 2011 Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. J Nutr Biochem 22:527-534
43. Kudo H, Takahara T, Yata Y, Kawai K, Zhang W, Sugiyama T 2009 Lipopolysaccharide triggered TNF-α-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model. J Hepatol 51:168-175
44. Kojima H, Sakurai S, Uemura M, Fukui H, Morimoto H, Tamagawa Y 2007 Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis. Alcohol Clin Exp Res 31:S61-S66
45. Zhang W, Kudo H, Kawai K, Fujisaka S, Usui I, Sugiyama T, Tsukada K, Chen N, Takahara T 2010 Tumor necrosis factor-α accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease. Biochem Biophys Res Commun 391:1731-1736
46. Kim F, Pham M, Maloney E, Rizzo NO, Morton GJ, Wisse BE, Kirk EA, Chait A, Schwartz MW 2008 Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol 28:1982-1988
47. Valenca SS, Gouveia L, Pimenta WA, Porto LC 2008 Effects of oral nicotine on rat liver stereology. Int J Morphol 26:1013-1022
48. Aragno M, Tomasinelli CE, Vercellinatto I, Catalano MG, Collino M, Fantozzi R, Danni O, Boccuzzi G 2009 SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats. Free Radic Biol Med 47:1067-1074
49. El-Sokkary GH, Cuzzocrea S, Reiter RJ 2007 Effect of chronic nicotine administration on the rat lung and liver: beneficial role of melatonin. Toxicology 239:60-67
50. Sreekala S, Indira M 2009 Effects of exogenous selenium on nicotine-induced oxidative stress in rats. Biol Trace Elem Res 130:62-71
51. Taysi S, Gumustekin K, Demircan B, Aktas O, Oztasan N, Akcay F, Suleyman H, Akar S, Dane S, Gul M 2010 Hippophae rhamnoides attenuates nicotine-induced oxidative stress in rat liver. Pharm Biol 48:488-493
52. Videla LA 2010 Cytoprotective and suicidal signaling in oxidative stress. Biol Res 43:363-369
53. Serviddio G, Bellanti F, Sastre J, Vendemiale G, Altomare E 2010 Targeting mitochondria: a new promising approach for the treatment of liver diseases. Curr Med Chem 17:2325-2337
54. Mihaylova MM, Shaw RJ 2011 The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 13:1016-1023
55. Kathirvel E, Morgan K, Nandgiri G, Sandoval BC, Caudill MA, Bottiglieri T, French SW, Morgan TR 2010 Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine. Am J Physiol Gastrointest Liver Physiol 299:G1068-G1077
56. Nakagawa H, Maeda S, Hikiba Y, Ohmae T, Shibata W, Yanai A, Sakamoto K, Ogura K, Noguchi T, Karin M, Ichijo H, Omata M 2008 Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation. Gastroenterology 135:1311-1321
57. Singh R, Wang Y, Schattenberg JM, Xiang Y, Czaja MJ 2009 Chronic oxidative stress sensitizes hepatocytes to death from 4-hydroxynonenal by JNK/c-Jun overactivation. Am J Physiol Gastrointest Liver Physiol 297:G907-G917
58. Cacicedo JM, Benjachareonwong S, Chou E, Yagihashi N, Ruderman NB, Ido Y 2011 Activation of AMP-activated protein kinase prevents lipotoxicity in retinal pericytes. Invest Ophthalmol Vis Sci 52:3630-3639
59. Jia F, Wu C, Chen Z, Lu G 2011 AMP-activated protein kinase inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells. Cardiovasc Drugs Ther 25:21-29
60. Meares GP, Hughes KJ, Jaimes KF, Salvatori AS, Rhodes CJ, Corbett JA 2010 AMP-activated protein kinase attenuates nitric oxide-induced β-cell death. J Biol Chem 285:3191-3200
61. Yen CY, Lin MH, Liu SY, Chiang WF, Hsieh WF, Cheng YC, Hsu KC, Liu YC 2011 Arecoline-mediated inhibition of AMP-activated protein kinase through reactive oxygen species is required for apoptosis induction. Oral Oncol 47:345-351
62. Andersson K, Arner P 2001 Systemic nicotine stimulates human adipose tissue lipolysis through local cholinergic and catecholaminergic receptors. Int J Obes Relat Metab Disord 25:1225-1232
63. An Z, Wang H, Song P, Zhang M, Geng X, Zou MH 2007 Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 adipocytes: a role of oxidant stress. J Biol Chem 282:26793-26801
64. Liu RH, Mizuta M, Matsukura S 2004 The expression and functional role of nicotinic acetylcholine receptors in rat adipocytes. J Pharmacol Exp Ther 310:52-58
65. Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, Lukas RJ, Markou A, Marks MJ, McCallum SE, Parameswaran N, Perkins KA, Picciotto MR, Quik M, Rose JE, Rothenfluh A, Schafer WR, Stolerman IP, Tyndale RF, Wehner JM, Zirger JM 2007 Guidelines on nicotine dose selection for in vivo research. Psychopharmacology 190:269-319